MYCO-005 is a serotonin 5-HT2A receptor agonist and psychedelic hallucinogen which is under development for the treatment of depressive disorders and anxiety disorders.
[1][2][4][3][5] It is a tryptamine derivative and an aza-indole analogue of psilocin.
[1][3] Activation of the serotonin 5-HT2B receptor is known to induce the development of cardiac valvulopathy and has been a concern with regard to chronic microdosing of psychedelics.
[6][7] Since MYCO-005 does not activate the serotonin 5-HT2B receptor, it is anticipated to be heart-safe and to be safer for use in the contexts of both macro- and microdosing than other psychedelics.
[1][2] The exact chemical structure of MYCO-005 does not yet seem to have been disclosed.